$ILNS News 10-Q: INTELLECT NEUROSCIENCES, INC.
Post# of 94145
Posted On: 05/01/2014 10:04:23 AM
$ILNS News
10-Q: INTELLECT NEUROSCIENCES, INC. 2:54 p.m. Feb. 14, 2014 - Edgar Online - (EDG = 10Q, 10K)
10-Q: INTELLECT NEUROSCIENCES, INC. 5:03 p.m. Nov. 19, 2013 - Edgar Online - (EDG = 10Q, 10K)
10-K: INTELLECT NEUROSCIENCES, INC. 5:31 p.m. Oct. 15, 2013 - Edgar Online - (EDG = 10Q, 10K)
10-Q: INTELLECT NEUROSCIENCES, INC. 3:41 p.m. May 20, 2013 - Edgar Online - (EDG = 10Q, 10K)
Revenues Fall at ViroPharma - Analyst Blog 1:30 p.m. Oct. 29, 2012 - Zacks.com
ViroPharma Beats; All Set to Shine - Analyst Blog 10:15 a.m. March 2, 2012 - Zacks.com
ViroPharma Going Strong - Analyst Blog 9:45 a.m. Oct. 31, 2011 - Zacks.com
Intellect Neurosciences, Inc. Announces Positive Top Line Data Showing Proof of Concept in a Preclinical Alzheimer's Model for Its TauC3 Monoclonal Antibody Indicating its Potential to be Disease Modifying 4:20 a.m. Jan. 16, 2014 - GlobeNewswire
Intellect Neurosciences Obtains Patent Allowance From the United States Patent and Trademark Office in Relation to Its TOC-1 Monoclonal Antibody Selective for Pre-Fibrillar Tau Aggregates 3:15 p.m. Nov. 14, 2013 - GlobeNewswire
Intellect Neurosciences Retains Chain Pharmaceuticals LLC 11:30 a.m. July 30, 2013 - GlobeNewswire
Intellect Neurosciences, Inc. Issues Letter to Shareholders 9:26 a.m. June 20, 2013 - GlobeNewswire
Intellect Neurosciences Engages Evli Corporate Finance to Explore Strategic Alternatives to Maximize Shareholder Value 11:31 a.m. June 18, 2013 - GlobeNewswire
10-Q: INTELLECT NEUROSCIENCES, INC. 2:54 p.m. Feb. 14, 2014 - Edgar Online - (EDG = 10Q, 10K)
10-Q: INTELLECT NEUROSCIENCES, INC. 5:03 p.m. Nov. 19, 2013 - Edgar Online - (EDG = 10Q, 10K)
10-K: INTELLECT NEUROSCIENCES, INC. 5:31 p.m. Oct. 15, 2013 - Edgar Online - (EDG = 10Q, 10K)
10-Q: INTELLECT NEUROSCIENCES, INC. 3:41 p.m. May 20, 2013 - Edgar Online - (EDG = 10Q, 10K)
Revenues Fall at ViroPharma - Analyst Blog 1:30 p.m. Oct. 29, 2012 - Zacks.com
ViroPharma Beats; All Set to Shine - Analyst Blog 10:15 a.m. March 2, 2012 - Zacks.com
ViroPharma Going Strong - Analyst Blog 9:45 a.m. Oct. 31, 2011 - Zacks.com
Intellect Neurosciences, Inc. Announces Positive Top Line Data Showing Proof of Concept in a Preclinical Alzheimer's Model for Its TauC3 Monoclonal Antibody Indicating its Potential to be Disease Modifying 4:20 a.m. Jan. 16, 2014 - GlobeNewswire
Intellect Neurosciences Obtains Patent Allowance From the United States Patent and Trademark Office in Relation to Its TOC-1 Monoclonal Antibody Selective for Pre-Fibrillar Tau Aggregates 3:15 p.m. Nov. 14, 2013 - GlobeNewswire
Intellect Neurosciences Retains Chain Pharmaceuticals LLC 11:30 a.m. July 30, 2013 - GlobeNewswire
Intellect Neurosciences, Inc. Issues Letter to Shareholders 9:26 a.m. June 20, 2013 - GlobeNewswire
Intellect Neurosciences Engages Evli Corporate Finance to Explore Strategic Alternatives to Maximize Shareholder Value 11:31 a.m. June 18, 2013 - GlobeNewswire
(0)
(0)Scroll down for more posts ▼